首页> 美国卫生研究院文献>Therapeutic Advances in Respiratory Disease >Use of functional respiratory imaging to characterize the effect of inhalation profile and particle size on lung deposition of inhaled corticosteroid/long-acting β2-agonists delivered via a pressurized metered-dose inhaler
【2h】

Use of functional respiratory imaging to characterize the effect of inhalation profile and particle size on lung deposition of inhaled corticosteroid/long-acting β2-agonists delivered via a pressurized metered-dose inhaler

机译:使用功能性呼吸成像来表征吸入轮廓和粒径对通过加压定量吸入器输送的吸入皮质类固醇/长效β2-激动剂的肺部沉积的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background:Functional respiratory imaging (FRI) uses three-dimensional models of human lungs and computational fluid dynamics to simulate functional changes within airways and predict the deposition of inhaled drugs. This study used FRI to model the effects of different patient inhalation and drug formulation factors on lung deposition of an inhaled corticosteroid/long-acting β2-agonist (ICS/LABA) combination, administered by a pressurized metered-dose inhaler.
机译:背景:功能性呼吸成像(FRI)使用人肺的三维模型和计算流体动力学来模拟气道内的功能变化并预测吸入药物的沉积。这项研究使用FRI来模拟不同的患者吸入和药物制剂因素对吸入皮质类固醇/长效β2-激动剂(ICS / LABA)组合的肺部沉积的影响,该组合由加压定量吸入器给药。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号